|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|
| OPERATING ACTIVITIES | ||||
| Net income | ||||
| Adjustments to reconcile net loss to net cash used by operating activities: | ||||
| Amortization | ||||
| Stock-based compensation expense | ||||
| Impairment of investment in affiliates | ||||
| Equity income in affiliates | ||||
| Other | ||||
| Dividends from affiliates | ||||
| Receivables from related-parties | ||||
| Deferred tax recovery | ||||
| Dividends from affiliates | ||||
| Changes in operating assets and liabilities: | ||||
| Receivables from related‑parties | ||||
| Accounts payable and other accrued liabilities | ||||
| Other current assets | ||||
| Net cash (used) provided by operating activities | ||||
| INVESTING ACTIVITIES | ||||
| Purchase of property, plant and equipment | ||||
| Investment in affiliates | ||||
| Capital distributions received from affiliate | ||||
| Net cash provided (used) by investing activities | ||||
| FINANCING ACTIVITIES | ||||
| Credit Facility (repayment) receipt | ||||
| Credit Facility repayment | ||||
| Financing costs | ||||
| Issuance of common stock | ||||
| Issuance of treasury stock | ||||
| Other | ||||
| Net cash used by financing activities | ||||
| Net increase (decrease) in cash and cash equivalents | ||||
| Net increase in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of period | ||||
| Cash and cash equivalents, end of period | ||||
| Interest paid | ||||
| Supplemental disclosure of noncash transactions: | ||||
| Director fees in accrued liabilities converted to deferred share units | ||||
| Recognition of Right of Use Asset and Lease Liability | ||||
Loading...